Remdesivir
Veklury (remdesivir) is a small molecule pharmaceutical. Remdesivir was first approved as Veklury on 2020-07-03. It is used to treat coronavirus and virus diseases in the USA. It has been approved in Europe to treat coronavirus infections. It is known to target ORF1a polyprotein;ORF1ab polyprotein, RNA-dependent RNA polymerase, and Replicase polyprotein 1ab. Veklury's patents are valid until 2038-07-10 (FDA).
| Trade Name | Veklury |
|---|---|
| Common Name | Remdesivir |
| ChEMBL ID | CHEMBL4065616 |
| Indication | coronavirus, coronavirus infections, virus diseases |
| Drug Class | Antivirals: adenosine analogs acting as RNA polymerase inhibitors |
